(Q45215887)

10 December 2017

title

Response to chemotherapy and treating institution predict survival in primary central nervous system lymphoma (English)

1 reference

10 December 2017

1 reference

Agnieszka Korfel

1

1 reference

10 December 2017

Peter Martus

2

1 reference

10 December 2017

Mohammad R Nowrousian

3

1 reference

10 December 2017

Dieter K Hossfeld

4

1 reference

10 December 2017

Heinz Kirchen

5

1 reference

10 December 2017

Joachim Brücher

6

1 reference

10 December 2017

Matthias Stelljes

7

1 reference

10 December 2017

Josef Birkmann

8

1 reference

10 December 2017

Christian Peschel

9

1 reference

10 December 2017

Rita Pasold

10

1 reference

10 December 2017

Lars Fischer

11

1 reference

10 December 2017

Kristoph Jahnke

12

1 reference

10 December 2017

Eckhard Thiel

13

1 reference

10 December 2017

German primary central nervous system lymphoma Study Group (G-PCNSL-SG)

14

1 reference

10 December 2017

language of work or name

English

0 references

publication date

1 January 2005

1 reference

British Journal of Haematology

10 December 2017

published in

1 reference

10 December 2017

volume

128

1 reference

10 December 2017

issue

2

1 reference

10 December 2017

page(s)

177-183

1 reference

Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10.

10 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05284.X

Therapeutic management of primary central nervous system lymphoma: lessons from prospective trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05284.X

A multicenter study of treatment of primary CNS lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05284.X

Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05284.X

Successful treatment of non-Hodgkin's lymphoma of the central nervous system with BMPD chemotherapy followed by radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05284.X

Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05284.X

Primary central nervous system non-Hodgkin's lymphoma (PCNSL): survival advantages with combined initial therapy? A final report of the North Central Cancer Treatment Group (NCCTG) Study 86-72-52.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05284.X

High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05284.X

Pharmacokinetics and toxicity of high-dose intravenous methotrexate in the treatment of leptomeningeal carcinomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05284.X

10.1111/J.1365-2141.2004.05284.X

21 January 2018

Identifiers

DOI

1 reference

10 December 2017

1 reference